| Patient | Samuel Johnson |
|---|---|
| Date of birth | 1709-09-18 |
| Identifiers | MRN HR-EN008-SYN-TD; SSN (made up) 000-08-7139 |
| Document date | 1765-04-20 |
| Author | Catriona Bell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week depression check, seen the same day by neurology. [S]
Mr. Johnson returns two weeks after starting sertraline 50 mg and is seen the same day by Dr. Hassan of neurology. He has taken it every morning. He had mild nausea for the first four days, which has passed, and no agitation or sleep change. His mood is no better yet; he still cannot write and has seen only one friend. The nurse called him after the first week, and he has had two psychotherapy sessions. He told Dr. Hassan about the movements and sounds he has made since boyhood, the urge he feels before each one, his habit of counting his steps at doorways and going back to start again if he gets it wrong, and his fear that all of this, with his low spirits, means he is going mad. [S]
| Element | Detail |
|---|---|
| Sertraline | 50 mg daily for two weeks, every dose taken |
| Side effects | Nausea for four days, resolved |
| Mood | PHQ-9 19 |
| Psychotherapy | Two sessions |
| Tics | Lifelong; urge before each; rituals at doorways |
| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Negative | Nausea resolved; no diarrhea or bleeding |
| Neurological | Positive | Motor and vocal tics as usual; no weakness, numbness, or headache |
| Psychiatric | Positive | Low mood, guilt, and poor concentration; no agitation; no thoughts of suicide or self-harm |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily in the morning | Oral route | 1765-04-06 to 1765-05-18 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1765-04-20 | Body height | 183 | cm | S |
| 1765-04-20 | Body weight | 97.6 | kg | S |
| 1765-04-20 | Body mass index (BMI) [Ratio] | 29.1 | kg/m2 | S |
| 1765-04-20 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1765-04-20 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1765-04-20 | Heart rate | 80 | /min | S |
| 1765-04-20 | Respiratory rate | 16 | /min | S |
| 1765-04-20 | Body temperature | 36.6 | Cel | S |
| 1765-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1765-04-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 19 | {score} | S |
Vital signs recorded on 1765-04-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Large man, untidy; blood pressure 126/80, pulse 80 |
| Neurological | Frequent brief head turns toward the right shoulder with shaking, trunk rocking, rubbing of the left knee, clucking and half-whistling sounds, and forceful exhalations; he can hold them back for a minute when asked, with mounting discomfort; normal tone, strength, reflexes, coordination, and gait; no chorea, dystonia, or tremor |
| Psychiatric | Psychomotor slowing; mood low; logical; no psychosis |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholy | active | confirmed | F33.2 | S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health. |
| Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requested | resolved | confirmed | F95.9 | S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation. |
| Tourette syndrome: multiple motor tics and vocal tics since childhood, with premonitory urges, brief suppressibility, and tic-related obsessive-compulsive symptoms (counting, evening-up, and threshold rituals); synthetic modern diagnosis by DSM-5 criteria at the neurology consultation, linked to the documented tics and to the retrospective diagnosis | active | confirmed | F95.2 | S — Synthetic modern diagnosis; the retrospective historical diagnosis is graded R and is not asserted as fact. |
| Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eye | active | confirmed | H54.42 | S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Depression measure (PHQ-9) | At baseline and at least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 19, from 21 |
| Medication safety | Sertraline adherence and adverse effects | Every visit in the acute phase; reassess at 2 weeks after starting and after each dose change | Completed today | Two-week check: every dose taken; nausea for four days, resolved; no activation |
| Medication safety | Interaction review (serotonergic drugs; NSAIDs and anticoagulants with an SSRI) | At the start and with any new medicine | Completed today | No other medicines; told to avoid tramadol, triptans without advice, St. John's wort, and regular NSAIDs |
| Survey | Suicide-risk review (PHQ-9 item 9 and structured questions since the last visit), safety plan, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; nurse phone check done at one week |
| Referral | Psychotherapy (cognitive behavioral therapy with behavioral activation) | Offer to all with moderate or severe depression | Completed today | Two sessions |
| Survey | Mood Disorder Questionnaire | Once at the start of a depression work-up | Up to date | 3 at intake, negative |
| Survey | Anxiety measure (GAD-7) | At baseline and with PHQ-9 reviews | Up to date | 12 at intake |
| Laboratory | Sodium on an SSRI | Baseline; recheck if symptoms or age 65 or older | Up to date | 140 mmol/L at intake |
| Survey | Tic severity (Yale Global Tic Severity Scale, recorded in the note; no LOINC code is used) | At diagnosis and periodically to judge the need for and response to treatment | Completed today | Total tic score 30 (motor 17, phonic 13); impairment 20 |
| Examination | Assessment for co-occurring conditions (obsessive-compulsive symptoms, ADHD, anxiety, depression) | At diagnosis | Completed today | Obsessive-compulsive symptoms mild (Y-BOCS 13); ADHD screen negative; depression and anxiety under treatment |
| Self-management | Psychoeducation about tics for him and, if he wishes, his household | At diagnosis | Completed today | Natural history of tics explained; tics are not a sign of losing his reason |
| Referral | Comprehensive Behavioral Intervention for Tics | Offer as an initial treatment option | Ordered | Eight sessions with a trained therapist |
| Medication safety | Tic-suppressing medication (alpha-2 agonist, aripiprazole, or other) | When tics cause impairment that behavioral therapy does not relieve | Not indicated | Behavioral therapy first; he prefers to avoid more medicine |
| Referral | Neurology consultation | At the start of evaluation | Completed today | Seen by Dr. Hassan today |
Goal progress:
Guideline basis: Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders (Pringsheim T, et al. Neurology 2019;92(19):896-906) (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: Visit in four weeks. Psychotherapy weekly. Behavioral therapy for tics to begin in two weeks. Next scheduled visit 1765-05-18: six-week depression review: sertraline dose increase; behavioral therapy for tics under way. [S]